TrademarkDir
DXPP
LIVE

Serial Number

97877454

Owner

First Ascent Biomedical Inc.

Attorney

Patricia L. Cotton

First Use Date

Feb 24, 2023

Filing Date

Apr 7, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DXPP Trademark

Serial Number: 97877454 • Registration: 7770975

DXPP is a trademark filed by First Ascent Biomedical Inc. on April 7, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

First Ascent Biomedical Inc. (4 trademarks)

1421 SW 107th Ave #427
Miami, FL 33174

Entity Type: 03

Trademark Details

Filing Date

April 7, 2023

Registration Date

April 22, 2025

First Use Anywhere

February 24, 2023

First Use in Commerce

February 24, 2023

Published for Opposition

February 6, 2024

Goods & Services

Pharmaceutical drug development services; Providing laboratory research services in the field of gene expression, namely, cancer biology

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 22, 2025 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 20, 2025 APRE
TEAS SECTION 7 REQUEST RECEIVED
Jul 24, 2025 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 22, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 22, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 2, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 2, 2025 CNPR
EXAMINER'S AMENDMENT ENTERED
Apr 2, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 2, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 2, 2025 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Apr 2, 2025 SNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 13, 2024 GNFN
FINAL REFUSAL E-MAILED
Dec 13, 2024 GNFR
SU - FINAL REFUSAL - WRITTEN
Dec 13, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2024 CRFA
ASSIGNED TO LIE
Nov 14, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 4, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 4, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jul 18, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 18, 2024 AITU
USE AMENDMENT FILED
Jun 5, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 5, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2024 CNSA
ASSIGNED TO EXAMINER
Jan 4, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 2, 2023 NWOS
NEW APPLICATION ENTERED
Apr 11, 2023 NWAP

Related Trademarks

More from this Owner

DXPP

DXPP

DXPP

DXPP

DXPP

DXPP

DRUG PREDICTION PLATFORM

DRUG PREDICTION PLATFORM